SEC EDGAR Filing Information

Form 10-Q -- Quarterly report [Sections 13 or 15(d)]

Period of Report: 2006-06-30
Filing Date Changed: 2006-08-10
Documents: 5

SEC Accession No.
0001193125-06-169627
Filing date: 2006-08-11
Accepted: 2006-08-10 18:01:54

Table of submitted documents:

Seq	Type	Document	Size	Description
1	10-Q	d10q.htm	1384422	FORM 10-Q
2	EX-31.1	dex311.htm	9912	SECTION 302 CEO CERTIFICATION
3	EX-31.2	dex312.htm	10033	SECTION 302 CFO CERTIFICATION
4	EX-32.1	dex321.htm	3051	SECTION 906 CEO CERTIFICATION
5	EX-32.2	dex322.htm	3211	SECTION 906 CFO CERTIFICATION

		0001193125-06-169627.txt	1412695	Complete submission text file

Filer Information:

US ONCOLOGY INC (Filer) (0000943061)
IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26190 | Film No.: 061022509
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Assistant Director 1

Business Address
16825 NORTHCHASE DR
STE 1300
HOUSTON TX 77060
2818732674

Mailing Address

US Oncology Holdings, Inc. (Filer) (0001333191)
IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-126922 | Film No.: 061022508
SIC: 8060 Services-Hospitals

Assistant Director 1

Business Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060
(832) 601-8766

Mailing Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060